The Femtech World Awards 2025, delivered in partnership with headline sponsor Planned Parenthood, celebrates the brightest lights in women's health innovation.
We will be celebrating some of the best examples of leadership, innovation and impact in key areas that affect women's health and wellbeing.
We encourage you to read about each category below and enter / nominate via the form at the bottom of this page. If you have any questions about what we are looking for in each category please email editor@aspectpublishing.co.uk
Key dates:
August 18: Nominations/entries open
February 12: Nominations/entries close
February 12 - early March: Shortlisting and judging proces
Late March: Winners announced during an online video presentation
Award categories
Research Project of the Year
sponsored by Future Fertility
Women's Cancer Innovation
sponsored by Endomag
Menstrual Health Innovation
sponsored by Clue
Maternity Health Innovation
sponsored by TeleScan
OB-GYN Innovation
sponsored by Elitone by Elidah
Fertility Innovation
sponsored by FinDBest IVF
Brain and Mental Health Innovation
sponsored by Women in Cloud
AI Innovation
sponsored by SiS
Menopause Innovation
sponsored by Cross Border Impact Ventures
Company of the Year
sponsored by Guidea
The Judge's Choice Award
sponsored by Planned Parenthood
Research Project of the Year
New technology and ways of working are helping to redefine what is possible for patients around the world. We are looking for the individuals or providers who has embraced innovation to give new hope and secure beyond-expectation outcomes, helping to create examples of best practice which set an example to the wider sector.
About the category sponsor
Future Fertility is the leader in AI-powered oocyte quality assessment, backed by the industry's largest and most diverse oocyte dataset. With an ability to seamlessly integrate into all laboratory set-ups, including time-lapse and microscope-only, Future Fertility’s clinically validated tools have been adopted in more than 25 countries. Personalised insights gained via Future Fertility’s oocyte quality reports empower clinicians, embryologists, and patients with more precise information to guide future treatment planning and manage expectations for success.
The Judges' Choice Award
The winner of this award is selected by our independent panel of femtech insiders, experts and stakeholders.
About the category sponsor
Planned Parenthood Federation of America (PPFA) is the nation’s leading provider of high-quality, affordable sexual and reproductive health care for all people, and the nation’s largest provider of sex education. With nearly 600 health centers across the country, Planned Parenthood organisations serve all patients with care and compassion, with respect, and without judgment, striving to create equitable access to health care. We do this because we care passionately about helping people lead healthier lives. PPFA is a 501(c)(3) charitable organisation that supports the independently incorporated Planned Parenthood affiliates operating health centers across the U.S.
Womens Cancer Innovation
Cancer is a major public health and economic issue. Female breast cancer is the most commonly diagnosed cancer in the world, with an estimated 2.3 million cases diagnosed globally in 2020 alone.
However, what once seemed impossible in cancer research is now a reality thanks to a number of technological innovations that have led to breakthroughs in the ways we diagnose, understand and treat cancer.
Through the Women’s Cancer Innovation Award, Femtech World aims to shine a light on the organisations devoted to transforming the future of cancer care for women worldwide.
About the category sponsor
At Endomag, we believe everyone deserves a better standard of cancer care. That’s why we design our magnetic technologies with both the clinician and patient in mind. Many leading hospitals across the world use our unique solutions to help breast cancer patients avoid surgery when it isn’t needed, and experience better outcomes when it is.
At the heart of the company’s technologies is the Sentimag® localisation system. The Sentimag® system features a probe which works like a metal detector. When it is placed near the skin’s surface, it can detect Endomag’s magnetic seed marker (Magseed®) and liquid tracer (Magtrace®), for accurate lesion localisation and sentinel lymph node biopsy procedures.
Menstrual Health Innovation
The Menstrual Health Company of the Year award celebrates a company that has shown remarkable innovation and dedication to advancing menstrual health. This award honours a business that has made a significant impact by developing products, services or technologies that improve menstrual care, break stigmas, and enhance the lives of women everywhere.
About the category sponsor
Clue is a period tracking app, a trusted menstrual health resource, and a thought leader in femtech. By combining science and technology, we are actively changing the way people learn, access, and talk about menstrual and reproductive health around the world.
Our content is science-based and written by reproductive healthcare clinicians and science writers to provide people with essential, evidence-based education about health, periods, and sex via helloclue.com.
Maternity Health Innovation
The Maternity Health Innovation of the Year award honors a groundbreaking innovation that has significantly advanced the field of maternity care. This award recognises a product, service or technology that has improved maternal health outcomes, enhanced the pregnancy and childbirth experience, or provided critical support to mothers and babies.
About the category sponsor
At TeleScan, we're on a mission to improve health outcomes through innovative ultrasound technology. Too many patients will never see a bedside sonographer during their pregnancy, so TeleScan increases access through a telesonography® solution. Our software connects providers and their patients with remote perinatal sonographers. By offering high-quality diagnostics, we can identify high-risk pregnancies, intervene early, and improve maternal outcomes. Our partners include large hospital systems, private practices, and federally qualified healthcare centers in underserved locations across the U.S. To learn more, visit telescan.ai.
OB/GYN Innovation
The OB/GYN Innovation of the Year award recognises a pioneering advancement that has transformed obstetrics and gynecology. This award celebrates an innovation that has significantly improved women's reproductive health, from diagnosis and treatment to overall patient care.
About the category sponsor
Elidah, a medical equipment manufacturer, serves as a women's health leader for the home. Elitone is recognised as the first and only non-intrusive treatment for stress, mixed, and urge bladder leaks. It remains non-intrusive both physically and in terms of time, allowing individuals to undergo treatment while engaging in other tasks. The device addresses the common issue of bladder leaks experienced by 1 in 3 women, whether occurring during sneezing and coughing or due to the urgency of an overactive bladder. Elitone offers devices specifically designed to address and treat these concerns.
Fertility Innovation
Through the Fertility Innovation, the Femtech World Awards aim to shine a light on the life-changing work of those developing next-generation innovations that could not only increase success rates but revolutionise the world of reproductive health as we know it.
About the category sponsor
FinDBest IVF is where innovation meets efficiency in the IVF medical device market. We connect IVF medical device manufacturers with over 750 pre-vetted distributors in over 150 countries. Supported by seasoned MedTech experts, we ensure quality partnerships, global reach, and a user-friendly interface. Stay informed with insights on key IVF/ART events. Join us to unlock new opportunities, expand your market, and support couples on their parenthood journey. IVFTechnology #MedicalDevices #GlobalDistribution #InnovationInHealthcare
Brain and Mental Health Innovation
The Brain and Mental Health Innovation of the Year award honours a breakthrough innovation that has made a profound impact on the understanding, treatment, or management of brain and mental health conditions. This award recognises an innovation that has advanced the field by improving patient outcomes, increasing accessibility to care or offering new insights into mental wellness.
About the category sponsor
Women in Cloud is a community-led economic development organization taking action to generate $1B in net new global economic access for women entrepreneurs by 2030 through partnerships with corporations, community leaders, and policy makers. The Women in Cloud Initiative is led in collaboration with industry and community partners such as Microsoft, M12 - Microsoft's Venture Capital Fund, Accenture, Hitachi Solutions, Insight, Boeing, Meylah, and more. Learn more and get involved at https://www.womenincloud.com/.
AI Innovation
AI is helping to transform healthcare outcomes around the world by aiding diagnosis, freeing up clinician time and advancing drug discovery.
This award will recognise the AI innovators leading the field in this emerging space and making an impact where it matters most.
About the category sponsor
SiS: Women’s Health is a global platform driving impact in women’s health through innovation. We empower founders to transform their solutions into scalable, investible businesses by connecting them with a dynamic network of corporations, investors, and ecosystem enablers. Our initiatives include industry-leading events in London and New York, our proprietary matchmaking ‘SiStem’ that links founders with strategic partners, and corporate accelerator programs that help corporations scout, invest, and acquire new opportunities.
Menopause Innovation
The Menopause Innovation of the Year award celebrates a pioneering advancement that has significantly improved the experience and care for those going through menopause. This award will highlight innovations that have provided new solutions for managing menopausal symptoms, improving quality of life, and empowering individuals with knowledge and support.
About the category sponsor
Cross-Border Impact Ventures is an impact venture capital firm. We target both financial returns in line with venture returns and positive impact on the health of women, children and adolescents inclusively and globally for each investment we make.
In North America and Europe, our impact is achieved through targeting health areas in deep need of investment. We measure women, children and adolescent users reached.
Company of the Year
The Femtech Company of the Year award recognises an outstanding organisation that has demonstrated exceptional innovation, impact and leadership in the female technology sector. This award honours a company that has made significant strides in improving women's health and well-being through cutting-edge technology, products or services
About the category sponsor
Guidea is a product design agency at the forefront of digital health design, defining experiences that have touched +600M lives worldwide. With a client portfolio including dozens of live products, clinical trials, and FDA approvals, Guidea has created transformative solutions through research, design, and commercial product launch for top health companies, leading medical schools, and pharma companies. From start-up to enterprise organisation, Guidea’s collaborations consistently deliver meaningful and award-winning improvements for patient outcomes, and raise the standard for digital health care.
Built with Shorthand